Skip to content

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Development of Assessment Method of Driving Ability Using Driving Simulator in Healthy Volunteers #1: Measurement Setup of Assessment Criteria for Driving Ability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03278080
Enrollment
20
Registered
2017-09-11
Start date
2017-09-22
Completion date
2017-10-25
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Participants

Brief summary

The purpose of this study is to set an optimal measurement time for assessing driving ability in a driving simulator in healthy volunteers.

Interventions

Driving with simulator program for SDLP measurement

Driving with simulator program for DCV measurement

Driving with simulator program for BRT measurement

Sponsors

Nagoya University
CollaboratorOTHER
Taisho Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
21 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index (BMI) ≥18.5 and \<25.0 kg/m2 at screening inspection * No visual impairment (enable to correct the vision with eyeglasses or contact lens) * Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study

Exclusion criteria

* History of drug and food allergy * Routinely drink alcohol before bedtime * Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Design outcomes

Primary

MeasureTime frame
Standard Deviation of Lateral Position (SDLP)60 min.

Secondary

MeasureTime frame
Distance Coefficient of Variation (DCV)25 min.
Brake Reaction Time (BRT)15 min.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026